RAN and cancer: We and others have shown that Ran inhibition using siRNA/shRNA is toxic for cancer cells both in vitro and in vivo, irrespectively of their origin or genetic background (Barres et al., 2010; Yuen et al., 2012, 2013; Deng et al., 2014; Schnepp et al., 2015).